Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Cedar, founded in 2016 and headquartered in New York, is a leading enterprise fintech platform focused on reducing administrative friction in the healthcare system. The company's innovative solutions connect providers and payers, optimizing the patient experience from pre-service through payment without using overly technical language. Cedar's platform integrates seamlessly with electronic health records (EHRs) to enhance the end-to-end digital patient experience.
Since its inception, Cedar has demonstrated impressive growth and attracted significant investor interest. The company has successfully raised $350.81 million across multiple funding rounds, with its latest Series D - II round in December 2022 valuing the company at $3.2 billion. This substantial valuation reflects the market's confidence in Cedar's potential and the growing demand for efficient healthcare payment solutions.
While there is no official news regarding Cedar's IPO prospects, the company's strong financial backing and innovative approach to healthcare fintech have positioned it as a notable player in the industry. Cedar's impressive list of investors, including Andreessen Horowitz, Thrive Capital, and Tiger Global Management, further underscores its potential for future growth.
Factors that may influence Cedar's decision to go public include market conditions, the company's financial performance, and its long-term strategic goals. However, it's important to note that any discussions about a potential Cedar IPO remain speculative at this time. As with any private company, the decision to pursue an initial public offering will ultimately depend on various internal and external factors.
Investors interested in the healthcare technology sector should keep an eye on Cedar's progress, as the company continues to revolutionize the patient financial experience in healthcare. While the possibility of investing in Cedar stock or buying Cedar shares is not currently available to the public, the company's innovative solutions and strong market position make it a noteworthy entity in the healthcare fintech landscape.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Cedar's IPO prospects remain uncertain, investors interested in the healthcare technology sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Cedar, with lower minimum investments than traditional private equity channels. By leveraging our expertise in identifying high-potential companies, we help accredited investors diversify their portfolios with pre-IPO investments in the innovative healthcare technology space.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
